AXIN2 and colorectal cancer: Seeking orthogonal evidence, we examined the change in AXIN2 expression for the collection of MSS colorectal cancers for which both mutational and RNA sequencing (RNA-seq) data were available (n = 89 samples from 100kGP; n = 243 samples from TCGA).